Clinical Trial Update: Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the combination of sitagliptin (a DPP-4 inhibitor) with NPH insulin in adults with Type 2 Diabetes Mellitus. The trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)
• insulin NPH (insulin NPH)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED